As all arthritis sufferers are aware, there is a great need for an arthritis drug that really works and continues working. Good news this week is that a US company has been given permission to resume studies on an experimental arthritis drug. The study was halted for a while as you notice in the below article, but it's good to see the necessary investigations were made, and the drug has been cleared of any involvement, so here's hoping further research will uncover a medication that will be of benefit to many.
Article Source: http://english.people.com.cn/90001/90782/90880/6310538.html
Drug developer Targeted Genetics Corp. said Monday it will resume the study of an experimental arthritis drug that was halted in July after the unexpected death of a patient.
The U.S. Food and Drug Administration gave the Seattle-based company permission to continue the trial after reviewing information on all 127 patients, including a 36-year-old woman who died a few weeks after receiving the drug.
The woman's family and government scientists have questioned whether a genetically modified virus used when the drug is injected played a role in her death. However, government advisers for the National Institutes of Health said earlier this year that the woman probably died of an unrelated fungal infection.
The company's own investigation reached a similar conclusion earlier this month, noting that only trace amounts of the virus were found in the woman's body.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment